I
IMAX CORP
IMAXCIK 0000921582NYSELarge AcceleratedPhotographic Equipment & SuppliesA6CAFY ends Dec 31
Period
FY 2025
Revenue
$410.21M
Net Income
$34.88M
Total Assets
$894.03M
Equity
$337.89M
Shares Out
54.86M
Op. Cash Flow
$127.07M
Business
IMAX CORP is a global entertainment technology company that provides an end-to-end platform for immersive cinematic and live event experiences. It remasters films into IMAX formats and sells or leases premium theater systems featuring proprietary projection, sound, screen and auditorium architecture. The company operates through Content Solutions, focusing on content enhancement and distribution, and Technology Products and Services, which covers IMAX Systems sales, leases and maintenance, plus a Streaming and Consumer Technology unit. IMAX distributes content and systems worldwide via a direct sales force, exhibitors, institutional partners and streaming/device partnerships.
Summary from filing dated 2025-02-19
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 410 | 352 | 375 | 301 | 255 | |
| Total Costs and Expenses Applicable to Revenues | 164 | 162 | 160 | 144 | 120 | |
| Gross margin | 246 | 190 | 214 | 156 | 134 | |
| Selling, general and administrative expenses | 138 | 133 | 144 | 138 | 117 | |
| Research and development | 6 | 5 | 10 | 5 | 7 | |
| Amortization of intangible assets | 8 | 6 | 5 | 5 | 5 | |
| Credit loss expense (reversal), net | 696,000 | −973,000 | 2 | 9 | — | |
| Asset impairments | 0 | 0 | 144,000 | — | — | |
| Goodwill impairment | 7 | 0 | 0 | — | — | |
| Restructuring charges and other impairments | 3 | 4 | 3 | 0 | — | |
| Income from operations | 84 | 44 | 50 | −5 | 11 | |
| Realized and unrealized investment (losses) gains | −867,000 | 127,000 | 465,000 | 70,000 | 5 | |
| Retirement benefits non-service expense | −243,000 | −387,000 | −411,000 | −556,000 | −463,000 | |
| Interest income | 3 | 2 | 2 | 1 | — | |
| Interest expense | −7 | −8 | −7 | −6 | — | |
| Induced conversion expense on settlement on convertible notes | −15 | 0 | 0 | — | — | |
| Income before taxes | 63 | 38 | 46 | −10 | 11 | |
| Income tax expense | −18 | −5 | −13 | −10 | −21 | |
| Net income | 46 | 33 | 33 | −20 | −10 | |
| Net income attributable to non-controlling interests | −11 | −7 | −8 | −3 | −13 | |
| Net income attributable to common shareholders | 35 | 26 | 25 | −23 | −22 | |
| Basic (in dollars per share) | 0.65 | 0.49 | 0.47 | −0.4 | −0.38 | |
| Diluted (in dollars per share) | 0.63 | 0.48 | 0.46 | −0.4 | −0.38 | |
| Basic (in shares) | 54 | 53 | 54 | 57 | 59 | |
| Diluted (in shares) | 56 | 54 | 55 | 57 | 59 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 151 | 101 | 76 | 97 | 190 | |
| Accounts receivable, net of allowance for credit losses | 108 | 108 | 136 | 136 | 110 | |
| Financing receivables, net of allowance for credit losses | 122 | 120 | 127 | — | — | |
| Variable consideration receivables, net of allowance for credit losses | 91 | 83 | 64 | 44 | 44 | |
| Inventories | 33 | 33 | 32 | 32 | 27 | |
| Prepaid expenses | 15 | 13 | 12 | 12 | 12 | |
| Film assets, net of accumulated amortization | 16 | 9 | 7 | 5 | 4 | |
| Property, plant and equipment, net of accumulated depreciation | 243 | 240 | 243 | 253 | 260 | |
| Other assets | 25 | 22 | 21 | 16 | 18 | |
| Deferred income tax assets, net of valuation allowance | 13 | 14 | 8 | 10 | 14 | |
| Goodwill | 46 | 53 | 53 | 53 | 39 | |
| Other intangible assets, net of accumulated amortization | 32 | 35 | 35 | 33 | 23 | |
| Total assets | 894 | 830 | 815 | 821 | 883 | |
| Accounts payable | 19 | 20 | 26 | 25 | 16 | |
| Accrued and other liabilities | 105 | 101 | 111 | 117 | 112 | |
| Deferred revenue | 50 | 53 | 67 | 71 | 81 | |
| Revolving credit facility borrowings, net of unamortized debt issuance costs | 35 | 36 | 23 | 36 | 2 | |
| Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs | 244 | 230 | 229 | 227 | 224 | |
| Deferred income tax liabilities | 13 | 13 | 13 | 15 | 18 | |
| Total liabilities | 466 | 452 | 469 | 491 | 453 | |
| Commitments, contingencies and guarantees (see Notes 14 and 15) | — | — | — | — | — | |
| Non-controlling interests | 666,000 | 680,000 | 658,000 | 722,000 | 758,000 | |
| Capital stock common shares no par value. Authorized Unlimited number. 53,921,676 issued and outstanding (December 31, 2024 52,946,200 issued and outstanding) | 419 | 401 | 389 | 377 | 410 | |
| Other equity | 165 | 185 | 185 | 186 | 175 | |
| Statutory surplus reserve | 4 | 4 | 4 | 4 | 4 | |
| Accumulated deficit | −240 | −275 | −293 | −293 | −235 | |
| Accumulated other comprehensive loss | −10 | −17 | −12 | −10 | 3 | |
| Total shareholders equity attributable to common shareholders | 338 | 299 | 273 | 263 | 356 | |
| Non-controlling interests | 89 | 78 | 72 | 66 | 74 | |
| Total shareholders equity | 427 | 378 | 345 | 329 | 430 | |
| Total liabilities and shareholders equity | 894 | 830 | 815 | 821 | 883 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 62 | 66 | 60 | 57 | 56 | |
| Amortization of deferred financing costs | 2 | 2 | 2 | 3 | 3 | |
| Write-downs, including goodwill and asset impairments | 9 | 4 | 2 | 7 | 2 | |
| Deferred income tax expense (benefit) | 772,000 | −6 | −1 | −2 | 3 | |
| Share-based and other non-cash compensation | 27 | 23 | 24 | 28 | 26 | |
| Unrealized foreign currency exchange gain | −134,000 | −3 | −212,000 | 1 | 256,000 | |
| Accounts receivable | −1 | 29 | −2 | −29 | −52 | |
| Inventories | −76,000 | −2 | −285,000 | −6 | 11 | |
| Film assets | −25 | −25 | −20 | −20 | −15 | |
| Deferred revenue | −2 | −14 | −4 | −12 | −7 | |
| Changes in other operating assets and liabilities | −7 | −35 | −36 | 801,000 | −2 | |
| Net cash provided by operating activities | 127 | 71 | 59 | 17 | 6 | |
| Purchase of property, plant and equipment | −8 | −8 | −6 | −8 | −4 | |
| Investment in equipment for joint revenue sharing arrangements | −28 | −24 | −18 | −20 | −10 | |
| Acquisition of other intangible assets | −5 | −8 | −8 | −4 | −4 | |
| Proceeds from sale of equity securities | 0 | 0 | 1 | 0 | 18 | |
| Net cash used in investing activities | −42 | −41 | −32 | −53 | −7,000 | |
| Proceeds from issuance of convertible notes, net | 243 | 0 | 0 | — | 224 | |
| Redemption of capped calls related to convertible notes | 31 | 0 | 0 | — | — | |
| Debt issuance costs related to convertible notes | −24,000 | 0 | 0 | — | −1 | |
| Cash paid related to repurchase of convertible notes | −275 | 0 | 0 | — | — | |
| Purchase of capped calls related to convertible notes | −22 | 0 | 0 | — | −19 | |
| Proceeds from revolving credit facility borrowings | 109 | 55 | 40 | 38 | 4 | |
| Repayments of revolving credit facility borrowings | −109 | −42 | −53 | −4 | −308 | |
| Proceeds from other borrowings | 0 | 0 | 322,000 | 0 | — | |
| Repayment of other borrowings | −1 | −874,000 | −53,000 | 0 | — | |
| Credit facility amendment fees paid | −2 | 0 | −46,000 | −2 | −527,000 | |
| Taxes withheld and paid on employee stock awards vested | −10 | −5 | −6 | −4 | −4 | |
| Common shares issued - stock options exercised | 4 | 5 | 0 | 0 | 883,000 | |
| Principal payment under finance lease obligations | 0 | −509,000 | −480,000 | −948,000 | — | |
| Dividends paid to non-controlling interests | 0 | 0 | −1 | −3 | −5 | |
| Net cash used in financing activities | −34 | −6 | −49 | −59 | −133 | |
| Effects of exchange rate changes on cash | −497,000 | 812,000 | 504,000 | 2 | −1 | |
| Increase (decrease) in cash and cash equivalents during year | 51 | 24 | −21 | −92 | −128 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro